strategic · US
Abbott Laboratories
aka Abbott
Diversified diagnostics and medical-devices multinational (NYSE: ABT). Anchor strategic investor in NVision Imaging's 2026-05-13 $55M Series B financing as the sole strategic-investor lead; engagement scope is hyperpolarised-MRI diagnostic-agent commercialization plus the new PIQC drug-discovery platform.
PORTFOLIO 1 company
| Company | Domain | Modality | Country | Last joint event | Joint events |
|---|---|---|---|---|---|
| NVision Imaging Technologies | sensing | — | DE | 2026-05-13 | 1 |
ROUNDS PARTICIPATED · 90D View all 1 event involving Abbott Laboratories →
ROUNDS LED View all rounds led by Abbott Laboratories →